Actas de congresos
Second Brazilian Consensus Conference On Helicobacter Pylori Infection [ii Consenso Brasileiro Sobre Helicobacter Pylori]
Registro en:
Arquivos De Gastroenterologia. , v. 42, n. 2, p. 128 - 132, 2005.
42803
2-s2.0-23644431875
Autor
Coelho L.G.V.
Zaterka S.
Institución
Resumen
Significant progress has been obtained since the First Brazilian Consensus Conference on H. pylori Infection held in 1995, in Belo Horizonte, MG, and justify a second meeting to establish updated guidelines on the current management of H. pylori infection. The Second Brazilian Consensus Conference on H. pylori Infection was organized by the Brazilian Federation of Gastroenterology and Brazilian Nucleus for the Study of Helicobacter and took place on June, 19-20, 2004 in São Paulo, SP. Thirty six delegates coming from 15 different Brazilian states including gastroenterologists, pathologists, microbiologists and pediatricians undertook the meeting. The participants were allocated in one the five main topics of the meeting: H. pylori and dyspepsia, H. pylori and NSAIDs, H. pylori and gastroesophageal reflux disease, H. pylori treatment, and H. pylori retreatment. Seventy per cent and more votes were considered as acceptance for the final statement. The results were presented during a special session on the VI Brazilian Week of Digestive System, in Recife, PE (October 2004), and this publication represents the summary of the main recommendations and conclusions emerged from the meeting. 42 2 128 132 Coelho, L.G., León-Barúa, R., Quigley, E.M., Latin-American Consensus Conference on Helicobacter pylori Infection (2000) Am J Gastroenterol, 95, pp. 2688-2691 Coelho, L.G.V., Barros, C.A.S., Lima, D.C.A., Barbosa, A.J.A., Magalães, A.F.N., Oliveira, C.A., Queiroz, D.M.M., Zaterka, S., Consenso Nacional sobre H. pylori e afecções associadas (1996) GED Gastroenterol Endosc Dig, 15, pp. 53-58 Coelho, L.G.V., Mattos, A.A., Francisconi, C.F.M., Castro, L.P., André, S.B., Eficácia do regime terapêutico empregando a associação de pantoprazol, claritromicina e amoxicilina, durante uma semana, na erradicação do Helicobacter pylori em pacientes com úlcera péptica (2004) Arq Gastroenterol, 41, pp. 71-76 Coelho, L.G.V., Moretzsohn, L.D., Vieira, W.L.S., Gallo, M.A., Passos, M.C.F., Cindr, J.M., Cerqueira, M.C., Castro, L.P., New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures. A pilot study (2005) Aliment Pharmacol Ther, 21, pp. 783-787 Current European Concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report (1997) Gut, 41, pp. 8-13 Dani, R., Queiroz, D.M., Dias, M.G., Franco, J.M., Magalhães, L.C., Mendes, G.S., Moreira, L.S., Salles, P.G., Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer (1999) Aliment Pharmacol Ther, 13, pp. 1647-1652 Graham, D.Y., Belson, G., Abudayyeh, S., Osato, M.S., El-Zimaity, H.M.T., Dore, M.P., Twice a day (mid-day and evening), quadruple therapy for H. pylori in the United States (2004) Dig Liver Dis, 36, pp. 377-379 Janowitz, H.D., Abittan, C.S., Fiedler, L.M., A gastroenterological list for the millennium (1999) J Clin Gastroenterol, 29, pp. 336-338 Kawakami, E., Ogata, S.K., Portorreal, A.C., Magni, A.M., Pardo, M.L., Patrício, F.R., Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents (2001) Arq Gastroenterol, 38, pp. 203-206 Lam, S.K., Talley, N.J., Helicobacter pylori Consensus. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection (1998) J Gastroenterol Hepatol, 13, pp. 1-12 Magalhaes, A.F., Macedo, C., Hauck, J.R., Carvalhaes, A., De Nucci, G., Magna, L.A., Pedrazzoli, J., Acid suppression with ranitidine plus oral triple therapy improves ulcer healing but not Helicobacter pylori eradication (1998) Hepatogastroenterology, 45, pp. 2161-2164 Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A.P., Jones, R., Axon, A., Graham, D.Y., Tytgat, G., Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report (2002) Aliment Pharmacol Ther, 16, pp. 167-180 Marshall, B.J., Warren, J.R., Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration (1984) Lancet, 1, pp. 1311-1315 Mazzoleni, L.E., (2003) Beneficio Sintomatico em População de Pacientes com Dispepsia Funcional Após a Erradicação do Helicobacter Pylori: Resultado de Estudo de 12 Meses, Randomizado, Duplo-cego, Controlado com Placebo, , [tese]. Porto Alegre: Universidade Federal do Rio Grande do Sul Helicobacter pylori in peptic ulcer disease (1994) JAMA, 272, pp. 65-69 Nista, E.C., Candelli, M., Cremonini, F., Cazzato, I.A., Di Caro, S., Gabrielli, M., Santarelli, L., Gasbarrini, A., Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: A randomized trial (2003) Aliment Pharmacol Ther, 18, pp. 627-633 Orsi, P., Pinazzi, O., Aragona, G., Di Mario, F., Rabeprazol/levofloxacin based triple therapy as a salvatage treatment after failure of H. pylori eradication with standard regimens (2003) Helicobacter, 8, pp. 463-464 Passes, M.C.F., (1999) Ensaio Prospective, Randomizado, Duplo Cego, Placebo-controlado do Efeito da Erradicação do Helicobacter Pylori nos Pacientes Dispépticos Funcionais, , [dissertação]. Belo Horizonte: Universidade Federal de Minas Gerais Pinheiro, J.O.P., Both, C.T., Dietrich, S., Zamin, J.I., Raymondi, R.P., Muretti, I., Mattos, A.A., Tratamento do Helicobacter pylori: Comparação de dois esquemas terapêuticos (1999) GED Gastroenterol Endosc Dig, 18, pp. 97-101 Sherwood, L.G., Bismuth therapy in gastrointestinal disease (1990) Gastroenterology, 99, pp. 863-875 Silva, F.M., Eisig, J.N., Chehter, E.Z., Silva, J.J., Laudanna, A.A., Omeprazole, furazolidone, and tetracycline: An eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease (2002) Rev Hosp Clin Fac Med São Paulo, 57, pp. 205-208 Talley, N.J., Stanghellini, V., Heading, R.C., Koch, K.L., Malagelada, J.R., Tytgat, G.N.J., Functional gastroduodenal disorders (2000) Rome II: The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment: A Multinational Consensus. 2 nd Ed., pp. 299-350. , Drossman DA, Corazziari E, Talley NJ, Thompson G, Whitehead WE, editors. McLean, Virginia. Degnon Associates Tytgat, G.N.T., (1990) Working Party Report of the World Congress of Gastroenterology. Helicobacter Pylori: Causal Agent in Peptic Ulcer Disease?, , Sydney, Australia Vieira, W.L.S., Coelho, L.G.V., Castro, F.J., Passos, M.C.F., Franco, J.M.M., Moretzsohn, L.D., Trindade, O.R., Castro, L.P., Terapia tripla com lansoprazol, claritromicina e amoxicilina, por dez dias, na erradicação do Helicobacter pylori em pacientes com ulcera duodenal (2001) GED Gastroenterol Endosopia Digestiva, 20, pp. 201-207 Vieira, W.L.S., (2002) Retratamento da Infecção pelo Helicobacter Pylori em Pacientes Portadores de Úlcra Duodenal e Seguimento a Longo Prazo. Ensaio Clínico, Aberto, Prospective e Randomizado Com Dosagens Séricas e Urinárias de Antimicrobianos, , [tese]. Belo Horizonte: Universidade Federal de Minas Gerais Zullo, A., Hassan, C., De Francesco, V., Lorenzetti, R., Marignani, M., Angeletti, S., Ierardi, E., Morini, S., A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication (2003) Dig Liver Dis, 35, pp. 232-236